{"name":"Keun-Sik Hong","slug":"keun-sik-hong","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Experimental: Rosuvastatin/Ezetimibe 10","genericName":"Experimental: Rosuvastatin/Ezetimibe 10","slug":"experimental-rosuvastatin-ezetimibe-10","indication":"Hypercholesterolemia and dyslipidemia for cardiovascular risk reduction","status":"marketed"}]}],"pipeline":[{"name":"Experimental: Rosuvastatin/Ezetimibe 10","genericName":"Experimental: Rosuvastatin/Ezetimibe 10","slug":"experimental-rosuvastatin-ezetimibe-10","phase":"marketed","mechanism":"This combination reduces LDL cholesterol by inhibiting HMG-CoA reductase (rosuvastatin) and blocking intestinal cholesterol absorption (ezetimibe).","indications":["Hypercholesterolemia and dyslipidemia for cardiovascular risk reduction"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNZjhmeUhhNU43N1pGMXBla3JONlpnRnpCb3NUZTFLZnZlZVNmNHVNQjllU0c1RFBPQkhtdVRmLVZjRWRYWl9HNHhmcXZFd2tBOTZRTHFSMjhlM2xSV0hhTU00NFMyUTlUZklrRjBQdTNLRkhXbmFDZ0tJa3FYNmlXOTZReTJPSXZt0gGcAUFVX3lxTE9acTVCVkFxei16UjlaazVGN1FMZU4wU2VfQmp4U0NRY2dMOFcyci0xbUFHcTBrSDljT21SN05JdnhEamJfenJzNFVVdWpkUVFZSGl1eW45cXhQNXlERTJMVlR5bnFyd1FrU0VQWE1oaUQxRzBtVmJEa0xOd0Y0TXF5Qlo4ZlM3MWFhSXNPS2tNeWNKNjRaZDZhR3lHdA?oc=5","date":"2025-04-17","type":"deal","source":"Chosunbiz","summary":"Jang Geun-suk discusses ideal partner while showcasing luxury home on MBN show - CHOSUNBIZ - Chosunbiz","headline":"Jang Geun-suk discusses ideal partner while showcasing luxury home on MBN show - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE9hRFZKR3dHRG1LMkJFRjVTTXM1cUF2T3hKLUZxUFNYWVR5cmtiUEd0aVhxaElUS2hrX0d3THJkdFZONUtjMFdQVDJ2SzBBSXhrejdoazhIRnFteFRZbEF1LXRvNjhubFU5Nk4zYg?oc=5","date":"2019-12-20","type":"pipeline","source":"American Heart Association Journals","summary":"Cilostazol Versus Aspirin in Ischemic Stroke Patients With High-Risk Cerebral Hemorrhage: - American Heart Association Journals","headline":"Cilostazol Versus Aspirin in Ischemic Stroke Patients With High-Risk Cerebral Hemorrhage:","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}